4:00PM Trius Therapeutics: Cubist Pharmaceuticals commences tender offer for all outstanding shares of Trius Therapeutics for $13.50 per share plus one contingent value right (TSRX) 13.73 +0.03 : CBST announced the commencement of its tender offer for all outstanding shares of the common stock of Trius Therapeutics(TSRX) for $13.50/share in cash, plus one Contingent Value Right, entitling the holder to receive an additional cash payment of up to $2/share they tender if certain sales milestones are achieved. The tender offer is being made by BRGO Corporation, a wholly-owned subsidiary of Cubist, and is dated 7/30/13.
Seems a typo on "plus one Contingent value right". Sounds like total of 3 CVR ?? Am I misreading the briefing.com news ?
Market Data 
Markets 
AI
